A citation-based method for searching scientific literature

Hideo Shigematsu, Takayuki Kadoya, Norio Masumoto, Kazuo Matsuura, Akiko Emi, Keiko Kajitani, Ai Amioka, Morihito Okada. Clin Breast Cancer 2014
Times Cited: 10







List of co-cited articles
31 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.
N Avril, C A Rosé, M Schelling, J Dose, W Kuhn, S Bense, W Weber, S Ziegler, H Graeff, M Schwaiger. J Clin Oncol 2000
347
70

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
202
50

Positron emission tomography in breast cancer: a clinicopathological correlation of results.
A Y Rostom, J Powe, A Kandil, A Ezzat, S Bakheet, F el-Khwsky, G el-Hussainy, R Sorbris, O Sjoklint. Br J Radiol 1999
55
40

Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
Masahiro Ohara, Hideo Shigematsu, Yasuhiro Tsutani, Akiko Emi, Norio Masumoto, Shinji Ozaki, Takayuki Kadoya, Morihito Okada. Breast 2013
32
30

Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes.
Ayse Mavi, Muammer Urhan, Jian Q Yu, Hongming Zhuang, Mohamed Houseni, Tevfik F Cermik, Dhurairaj Thiruvenkatasamy, Brian Czerniecki, Mitchell Schnall, Abass Alavi. J Nucl Med 2006
121
30

Ductal carcinoma in situ: correlation between FDG-PET/CT and histopathology.
Asako Azuma, Mitsuhiro Tozaki, Kensuke Ito, Eisuke Fukuma, Tomoko Tanaka, Toshihiro O'uchi. Radiat Med 2008
11
30

Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
N Avril, M Menzel, J Dose, M Schelling, W Weber, F Jänicke, W Nathrath, M Schwaiger. J Nucl Med 2001
297
30

Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
Patrick G Morris, Gary A Ulaner, Anne Eaton, Maurizio Fazio, Komal Jhaveri, Sujata Patil, Laura Evangelista, Joseph Y Park, Cristian Serna-Tamayo, Jane Howard,[...]. Cancer 2012
46
20


Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
Shigeto Ueda, Hitoshi Tsuda, Hideki Asakawa, Takashi Shigekawa, Kazuhiko Fukatsu, Nobuo Kondo, Mikio Yamamoto, Yukihiro Hama, Katsumi Tamura, Jiro Ishida,[...]. Jpn J Clin Oncol 2008
150
20

SNM practice guideline for breast scintigraphy with breast-specific gamma-cameras 1.0.
Stanley J Goldsmith, Ward Parsons, Milton J Guiberteau, Lillian H Stern, Leora Lanzkowsky, Jean Weigert, Thomas F Heston, Elizabeth Jones, Jonathan Buscombe, Michael G Stabin. J Nucl Med Technol 2010
43
20

Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
Mary F Dillon, Enda W McDermott, Cecily M Quinn, Ann O'Doherty, Niall O'Higgins, Arnold D K Hill. J Surg Oncol 2006
69
20

Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer.
Florent Tixier, Catherine Cheze Le Rest, Mathieu Hatt, Nidal Albarghach, Olivier Pradier, Jean-Philippe Metges, Laurent Corcos, Dimitris Visvikis. J Nucl Med 2011
444
20

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.
Gary H Lyman, Sarah Temin, Stephen B Edge, Lisa A Newman, Roderick R Turner, Donald L Weaver, Al B Benson, Linda D Bosserman, Harold J Burstein, Hiram Cody,[...]. J Clin Oncol 2014
450
20

Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years.
Mattia Intra, Nicole Rotmensz, Paolo Veronesi, Marco Colleoni, Simona Iodice, Giovanni Paganelli, Giuseppe Viale, Umberto Veronesi. Ann Surg 2008
79
20

MRI of the breast in patients with DCIS to exclude the presence of invasive disease.
Eline E Deurloo, Jincey D Sriram, Hendrik J Teertstra, Claudette E Loo, Jelle Wesseling, Emiel J Th Rutgers, Kenneth G A Gilhuijs. Eur Radiol 2012
20
20

Ductal carcinoma in situ of the breast.
Harold J Burstein, Kornelia Polyak, Julia S Wong, Susan C Lester, Carolyn M Kaelin. N Engl J Med 2004
380
20


Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.
Kenjiro Aogi, Takayuki Kadoya, Yoshifumi Sugawara, Sachiko Kiyoto, Hideo Shigematsu, Norio Masumoto, Morihito Okada. Breast Cancer Res Treat 2015
44
20

Quantitation in positron emission computed tomography: 1. Effect of object size.
E J Hoffman, S C Huang, M E Phelps. J Comput Assist Tomogr 1979
965
20

Ductal carcinoma in-situ of the breast detected by [F-18] fluorodeoxyglucose positron emission tomography.
Tetsuhiro Owaki, Yuko Kijima, Heiji Yoshinaka, Yoshikazu Uenosono, Takako Yoshioka, Shoji Natsugoe, Takashi Aikou. Breast Cancer 2006
6
33

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
D C Allred, J M Harvey, M Berardo, G M Clark. Mod Pathol 1998
20

FDG-PET and beyond: molecular breast cancer imaging.
Andrew Quon, Sanjiv S Gambhir. J Clin Oncol 2005
100
20

Defining the role of PET-CT in staging early breast cancer.
Ashley M Groves, Manu Shastry, Simona Ben-Haim, Irfan Kayani, Anmol Malhotra, Timothy Davidson, Tina Kelleher, Diane Whittaker, Marie Meagher, Brian Holloway,[...]. Oncologist 2012
29
20


Occasional FDG PET recognition of in situ breast cancer.
B Vincenzi, A Calvieri, D Santini, V Altomare, G Tonini. Ann Oncol 2007
2
100



Clinicopathological Features of Cases with Primary Breast Cancer not Identified by 18F-FDG-PET.
Takaaki Fujii, Reina Yajima, Miki Tsuboi, Toru Higuchi, Sayaka Obayashi, Hideaki Tokiniwa, Rin Nagaoka, Daisuke Takata, Jun Horiguchi, Hiroyuki Kuwano. Anticancer Res 2016
5
40



A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.
U Veronesi, C De Cicco, V E Galimberti, J R Fernandez, N Rotmensz, G Viale, G Spano, A Luini, M Intra, P Veronesi,[...]. Ann Oncol 2007
108
10

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
Torsten O Nielsen, Forrest D Hsu, Kristin Jensen, Maggie Cheang, Gamze Karaca, Zhiyuan Hu, Tina Hernandez-Boussard, Chad Livasy, Dave Cowan, Lynn Dressler,[...]. Clin Cancer Res 2004
10

Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
A Gil-Rendo, F Martínez-Regueira, G Zornoza, M J García-Velloso, C Beorlegui, N Rodriguez-Spiteri. Br J Surg 2009
110
10

Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors.
Pierre Heudel, Sebastien Cimarelli, Anthony Montella, Catherine Bouteille, Thomas Mognetti. Int J Clin Oncol 2010
54
10

Additional value of PET-CT in staging of clinical stage IIB and III breast cancer.
Isabelle Segaert, Felix Mottaghy, Sarah Ceyssens, Walter De Wever, Sigrid Stroobants, Chantal Van Ongeval, Eric Van Limbergen, Hans Wildiers, Robert Paridaens, Ignace Vergote,[...]. Breast J 2010
58
10

Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer.
David Groheux, Elif Hindié, Sylvie Giacchetti, Anne-Sophie Hamy, Frederique Berger, Pascal Merlet, Anne de Roquancourt, Patricia de Cremoux, Michel Marty, Mathieu Hatt,[...]. Eur J Cancer 2014
37
10

Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors.
Naoki Ikenaga, Naoki Otomo, Atsushi Toyofuku, Yuji Ueda, Kiyokazu Toyoda, Tohru Hayashi, Kiyoshi Nishikawa, Masao Tanaka. Am Surg 2007
50
10

Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors.
Alexandre Cochet, Sophie Pigeonnat, Blandine Khoury, Jean-Marc Vrigneaud, Claude Touzery, Alina Berriolo-Riedinger, Inna Dygai-Cochet, Michel Toubeau, Olivier Humbert, Bruno Coudert,[...]. J Nucl Med 2012
37
10

Comparison between 18F-FDG PET image-derived indices for early prediction of response to neoadjuvant chemotherapy in breast cancer.
Mathieu Hatt, David Groheux, Antoine Martineau, Marc Espié, Elif Hindié, Sylvie Giacchetti, Anne de Roquancourt, Dimitris Visvikis, Catherine Cheze-Le Rest. J Nucl Med 2013
59
10

FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
Andreas Buck, Holger Schirrmeister, Thorsten Kühn, Changxian Shen, Thomas Kalker, Jörg Kotzerke, Anja Dankerl, Gerhard Glatting, Sven Reske, Torsten Mattfeldt. Eur J Nucl Med Mol Imaging 2002
206
10

Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience.
Jeryong Kim, Jinsun Lee, Eilsung Chang, Seongmin Kim, Kwangsun Suh, Jiyoung Sul, Insang Song, Yonghoon Kim, Chuljoo Lee. World J Surg 2009
45
10

Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer.
Rakesh Kumar, Anil Chauhan, Hongming Zhuang, Prem Chandra, Mitchell Schnall, Abass Alavi. Breast Cancer Res Treat 2006
127
10

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Kyung-Hun Lee, Seock-Ah Im, Do-Youn Oh, Se-Hoon Lee, Eui Kyu Chie, Wonshik Han, Dong-Wan Kim, Tae-You Kim, In Ae Park, Dong-Young Noh,[...]. BMC Cancer 2007
55
10

Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer.
David Groheux, Jean-Luc Moretti, Georges Baillet, Marc Espie, Sylvie Giacchetti, Elif Hindie, Christophe Hennequin, Jacques-Robert Vilcoq, Caroline Cuvier, Marie-Elisabeth Toubert,[...]. Int J Radiat Oncol Biol Phys 2008
84
10

Degree of tumor FDG uptake correlates with proliferation index in triple negative breast cancer.
Julia Tchou, Seema S Sonnad, Meredith R Bergey, Sandip Basu, John Tomaszewski, Abass Alavi, Mitchell Schnall. Mol Imaging Biol 2010
52
10

Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot study.
Nina Mortazavi-Jehanno, Anne-Laure Giraudet, Laurence Champion, Florence Lerebours, Elise Le Stanc, Veronique Edeline, Olivier Madar, Dominique Bellet, Alain Paul Pecking, Jean-Louis Alberini. Eur J Nucl Med Mol Imaging 2012
40
10

The Effects of Preoperative (18)F-FDG PET/CT in Breast Cancer Patients in Comparison to the Conventional Imaging Study.
Young Jin Choi, Young Duck Shin, Yoon Hee Kang, Moon Soo Lee, Min Koo Lee, Byung Sun Cho, Yoon Jung Kang, Ju Seung Park. J Breast Cancer 2012
34
10

Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
David Fuster, Joan Duch, Pilar Paredes, Martín Velasco, Montserrat Muñoz, Gorane Santamaría, Montserrat Fontanillas, Francesca Pons. J Clin Oncol 2008
182
10

[The role of / 18FDG PET/CT for the initial staging and therapy in primary breast cancer].
Masafumi Inokuchi, Hiroyuki Furukawa, Masato Kayahara, Tetsuo Ohta, Hiroko Kawashima, Junichi Taki, Seigo Kinuya. Gan To Kagaku Ryoho 2009
3
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.